The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Inhibition of Amyloid Formation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–280 of 280
Clusterin, a Binding Protein with a Molten Globule-like Region
Bailey, R. W., Dunker, A. K., Brown, C. J., Garner, E. C., & Griswold, M. D. (2001) · Biochemistry · doi:10.1021/bi010135x · Cited by 121
Lynch, S. M., Zhou, C., & Messer, A. C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.096 · Cited by 120
Perrier, V., Solassol, J., Crozet, C., Frobert, Y., Mourton-Gilles, C., Grassi, J. J., & Lehmann, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02356.x · Cited by 120
Herrera, F. E., Chesi, A., Paleologou, K. E., Schmid, A. W., Munoz, A., Vendruscolo, M., Gustincich, S., Lashuel, H. A., & Carloni, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003394 · Cited by 119
Yamada, K., Yabuki, C., Seubert, P., Schenk, D., Hori, Y., Ohtsuki, S., Terasaki, T., Hashimoto, T., & Iwatsubo, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2021-09.2009 · Cited by 117
Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models
Levites, Y., Smithson, L. A., Price, R. W., Dakin, R. S., Yuan, B., Sierks, M. R., Kim, J., McGowan, E., Kim Reed, D., Rosenberry, T. L., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6463fje · Cited by 116
Díaz, J. C., Šimáková, O., Jacobson, K. A., Arispe, N. J., & Pollard, H. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813355106 · Cited by 116
Inhibiting Aggregation of α-Synuclein with Human Single Chain Antibody Fragments
Emadi, S., Liu, R., Yuan, B., Schulz, P., McAllister, C., Lyubchenko, Y. L., Messer, A. C., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi036281f · Cited by 115
Dumoulin, M., Canet, D., Last, A. M., Pardon, E., Archer, D. B., Muyldermans, S., Wyns, L., Matagne, A., Robinson, C. V., Redfield, C., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.020 · Cited by 114
Ligand binding to distinct states diverts aggregation of an amyloid-forming protein
Woods, L. A., Platt, G. W., Hellewell, A. L., Hewitt, E. W., Homans, S. W., Ashcroft, A. E., & Radford, S. E. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.635 · Cited by 113
Effects of Various Flavonoids on the α -Synuclein Fibrillation Process
Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2010) · Parkinson s Disease · doi:10.4061/2010/650794 · Cited by 105
Small heat shock proteins inhibit in vitro Aβ1–42 amyloidogenesis
Kudva, Y. C., Hiddinga, H. J., Butler, P. C., Mueske, C. S., & Eberhardt, N. L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01180-0 · Cited by 103
Nilsson, S., Rask, L., & Peterson, P. A. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40795-3 · Cited by 99
Inhibition of insulin fibrillogenesis with targeted peptides
Gibson, T. J., & Murphy, R. M. (2006) · Protein Science · doi:10.1110/ps.051879606 · Cited by 98
Lendel, C., Bertoncini, C. W., Cremades, N., Waudby, C. A., Vendruscolo, M., Dobson, C. M., Schenk, D., Christodoulou, J., & Tóth, G. (2009) · Biochemistry · doi:10.1021/bi901285x · Cited by 98
Self-citationDesign of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR
Madine, J., Doig, A. J., & Middleton, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja075356q · Cited by 96
Yerbury, J. J., Kumita, J. R., Meehan, S., Dobson, C. M., & Wilson, M. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807242200 · Cited by 95
Meng, F., Marek, P., Potter, K. J., Verchere, C. B., & Raleigh, D. P. (2008) · Biochemistry · doi:10.1021/bi702518m · Cited by 95
Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis
Westermark, G. T., & Westermark, P. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.026 · Cited by 94
Johnson, S. M., Connelly, S., Wilson, I. A., & Kelly, J. W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801347s · Cited by 91
Tomiyama, T., Kaneko, H., Kataoka, K.-I., Asano, S., & Endo, N. (1997) · Biochemical Journal · doi:10.1042/bj3220859 · Cited by 91
Chen, J., Armstrong, A. H., Koehler, A. N., & Hecht, M. H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja107552s · Cited by 89
Structural Characterization of Clusterin-Chaperone Client Protein Complexes
Wyatt, A. R., Yerbury, J. J., & Wilson, M. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033688 · Cited by 84
Hockly, E., Tse, J., Barker, A. L., Moolman, D. L., Beunard, J., Revington, A. P., Holt, K., Sunshine, S., Moffitt, H., Sathasivam, K., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.007 · Cited by 84
Diagnostic and Therapeutic Potential of Amyloid-Reactive IgG Antibodies Contained in Human Sera
O’Nuallain, B., Hrncic, R., Wall, J. S., Weiss, D. T., & Solomon, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7071 · Cited by 84
Drugs: A tangled web of targets
Gravitz, L. (2011) · Nature · doi:10.1038/475s9a · Cited by 81
Interactions between Amyloidophilic Dyes and Their Relevance to Studies of Amyloid Inhibitors
Buell, A. K., Dobson, C. M., Knowles, T. P. J., & Welland, M. E. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.08.074 · Cited by 80
Sequestration of the Aβ Peptide Prevents Toxicity and Promotes Degradation In Vivo
Luheshi, L. M., Hoyer, W., de Barros, T. P., Härd, I. V. D., Brorsson, A., Macao, B., Persson, C., Crowther, D. C., Lomas, D. A., Ståhl, S., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000334 · Cited by 79
Self-citationMethylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
van Bebber, F., Paquet, D., Hruscha, A., Schmid, B., & Haass, C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.023 · Cited by 79
Antiprion immunotherapy: to suppress or to stimulate?
Aguzzi, A., & Sigurdson, C. J. (2004) · Nature reviews. Immunology · doi:10.1038/nri1437 · Cited by 78
Rosenmann, H., Meiner, Z., Geylis, V., Abramsky, O., & Steinitz, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.072 · Cited by 77
Detergent-like Interaction of Congo Red with the Amyloid β Peptide
Lendel, C., Bolognesi, B., Wahlström, A., Dobson, C. M., & Gräslund, A. (2010) · Biochemistry · doi:10.1021/bi902005t · Cited by 75
Self-citationScreening for Inhibitors of Tau Polymerization
Pickhardt, M., von Bergen�, M., Gažová, Z., Hascher, A., Biernat, J., Mandelkow, E., & Mandelkow�, E. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585891 · Cited by 74
PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines
Béringue, V., Vilette, D., Mallinson, G., Archer, F., Kaisar, M. E., Tayebi, M., Jackson, G. S., Clarke, A. R., Laude, H., Collinge, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402270200 · Cited by 74
Lam, A., Teplow, D. B., Stanley, E., & Urbanc, B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804984h · Cited by 73
Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation
Kim, C.-L., Karino, A., Ishiguro, N., Shinagawa, M., Sato, M., & Horiuchi, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80113-0 · Cited by 73
Watanabe, K., NAKAMURA, K. W., Akikusa, S., Okada, T., Kodaka, M., Konakahara, T., & Okuno, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6191 · Cited by 68
Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses
Almeida, M. R., Gales, L., Damas, A. M., Cardoso, I., & Saraiva, M. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774322076 · Cited by 68
Trapping of palindromic ligands within native transthyretin prevents amyloid formation
Kolstoe, S. E., Mangione, P. P., Bellotti, V., Taylor, G. W., Tennent, G. A., Deroo, S., Morrison, A. J., Cobb, A. J. A., Coyne, A. G., McCammon, M. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008255107 · Cited by 68
Pentapeptide Amides Interfere with the Aggregation of β-Amyloid Peptide of Alzheimer's Disease
Hetényi, C., Szabó, Z., Klement, É., Datki, Z., Körtvélyesi, T., Zarándi, M., & Penke, B. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6745 · Cited by 67
The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases
Cardinale, A., & Biocca, S. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.07.004 · Cited by 67
β 2 -microglobulin: from physiology to amyloidosis
Heegaard, N. H. H. (2009) · Amyloid · doi:10.1080/13506120903151775 · Cited by 66
Murphy, R. C., & Messer, A. C. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.011 · Cited by 64
Gibson, T. J., & Murphy, R. M. (2005) · Biochemistry · doi:10.1021/bi050225s · Cited by 62
Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders
Neff, F., Wei, X., Noelker, C., Bacher, M., Du, Y., & Dodel, R. C. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.010 · Cited by 62
Local Cooperativity in an Amyloidogenic State of Human Lysozyme Observed at Atomic Resolution
Dhulesia, A., Cremades, N., Kumita, J. R., Hsu, S. D., Mossuto, M. F., Dumoulin, M., Nietlispach, D., Akke, M., Salvatella, X., & Dobson, C. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103524m · Cited by 61
Gales, L., Macedo‐Ribeiro, S., Arsequell, G., Valencia, G., Saraiva, M. J., & Damas, A. M. (2005) · Biochemical Journal · doi:10.1042/bj20042035 · Cited by 61
The Subunit Structure of Human Thyroxine-binding Prealbumin
Rask, L., Peterson, P. A., & Nilsson, S. F. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61836-8 · Cited by 60
Antibody-based therapy in Alzheimer's disease
Pul, R., Dodel, R. C., & Stangel, M. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.552884 · Cited by 59
Palaninathan, S. K., Mohamedmohaideen, N. N., Orlandini, E., Ortore, G., Nencetti, S., Lapucci, A., Rossello, A., Freundlich, J. S., & Sacchettini, J. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006290 · Cited by 58
Bodles, A. M., El‐Agnaf, O. M. A., Greer, B., Guthrie, D. J. S., & Irvine, G. B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.077 · Cited by 58
Zhou, W., Gallagher, A., Hong, D.-P., Long, C., Fink, A. L., & Uversky, V. N. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.053 · Cited by 58
Larbig, G., Pickhardt, M., Lloyd, D. G., & Schmidt, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077250 · Cited by 58
Comparing the folding free‐energy landscapes of Aβ42 variants with different aggregation properties
Mitternacht, S., Staneva, I., Härd, T., & Irbäck, A. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22775 · Cited by 57
Self-citationLindhagen‐Persson, M., Brännström, K., Vestling, M., Steinitz, M. O., & Olofsson, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013928 · Cited by 57
N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy
Pickhardt, M., Biernat, J., Khlistunova, I., Wang, Y.-P., Gažová, Z., Mandelkow�, E., & Mandelkow�, E. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788765 · Cited by 57
Inhibition of Amyloid Fibrillization of Hen Egg-White Lysozymes by Rifampicin and p-Benzoquinone
Lieu, V. H., Wu, J. W., Wang, S. S. ‐., & Wu, C.-H. (2007) · Biotechnology Progress · doi:10.1021/bp060353n · Cited by 56
Gauci, A. J., Caruana, M., Giese, A., Scerri, C., & Vassallo, N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111061 · Cited by 54
Hawkes, C. A., Deng, L., Shaw, J. E., Nitz, M., & McLaurin, J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07052.x · Cited by 53
Human monoclonal antibodies against amyloid-beta from healthy adults
Geylis, V., Kourilov, V., Meiner, Z., Nennesmo, I., Bogdanović, N., & Steinitz, M. O. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.008 · Cited by 52
Phage Display Affords Peptides that Modulate β-Amyloid Aggregation
Orner, B. P., Liu, L., Murphy, R. M., & Kiessling, L. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0619861 · Cited by 52
Human Plasma Contains Cross-Reactive Aβ Conformer-Specific IgG Antibodies
O’Nuallain, B., Acero, L. F., Williams, A. D., McWilliams‐Koeppen, H. P., Weber, A., Schwarz, H. P., Wall, J. S., Weiss, D. T., & Solomon, A. (2008) · Biochemistry · doi:10.1021/bi801767k · Cited by 50
Protection against β-Amyloid-induced Apoptosis by Peptides Interacting with β-Amyloid
Nelson, T. J., & Alkon, D. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705558200 · Cited by 50
Design and biological activity of β-sheet breaker peptide conjugates
Rocha, S., Cardoso, I., Börner, H. G., Pereira, M. D. C., Saraiva, M. J., & Coelho, M. A. N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.090 · Cited by 47
Abelein, A., Bolognesi, B., Dobson, C. M., Gräslund, A., & Lendel, C. (2011) · Biochemistry · doi:10.1021/bi201745g · Cited by 45
Self-citationProbing the origins, diagnosis and treatment of amyloid diseases using antibodies
Dumoulin, M., & Dobson, C. M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.012 · Cited by 45
Smith, T. J., Stains, C. I., Meyer, S. C., & Ghosh, I. (2006) · Journal of the American Chemical Society · doi:10.1021/ja065557e · Cited by 45
Toward the Discovery of Effective Polycyclic Inhibitors of α-Synuclein Amyloid Assembly
Lamberto, G. R., Monserrat, V. T., Bertoncini, C. W., Salvatella, X., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.242958 · Cited by 44
Hoyer, W., & Härd, T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.040 · Cited by 43
Self-citationHaupt, C., Bereza, M., Kumar, S. T., Kieninger, B., Morgado, I., Hortschansky, P., Fritz, G., Röcken, C., Horn, U., & Fändrich, M. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.02.032 · Cited by 42
Liu, H., Funke, S. A., & Willbold, D. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0926 · Cited by 38
Haupt, C., Morgado, I. M., Kumar, S. T., Parthier, C., Bereza, M., Hortschansky, P., Stubbs, M. T., Horn, U., & Fändrich, M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.059 · Cited by 34
Inhibition of Tau Aggregation in Cell Models of Tauopathy
Khlistunova, I., Pickhardt, M., Biernat, J., Wang, Y., Mandelkow, E., & Mandelkow�, E. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018307 · Cited by 33
Lindgren, J., Wahlström, A., Danielsson, J., Markova, N., Ekblad, C., Gräslund, A., Abrahmsén, L., Karlström, A. E., & Wärmländer, S. K. T. S. (2010) · Protein Science · doi:10.1002/pro.511 · Cited by 32
High-Affinity Amphipathic Modulators of Amyloid Fibril Nucleation and Elongation
Ryan, T. M., Griffin, M. D. W., Teoh, C. L., Ooi, J., & Howlett, G. J. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.023 · Cited by 31
Studying the effects of chaperones on amyloid fibril formation
Zhang, H., Xu, L., & Perrett, S. (2010) · Methods · doi:10.1016/j.ymeth.2010.11.009 · Cited by 30
Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
O’Nuallain, B., Williams, A. D., McWilliams‐Koeppen, H. P., Acero, L. F., Weber, A., Ehrlich, H. J., Schwarz, H. P., & Solomon, A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9413-6 · Cited by 27
New Strategy for the Generation of Specific d-Peptide Amyloid Inhibitors
Esteras‐Chopo, A., Pastor, M. T., Serrano, L. G., & de la Paz, M. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.028 · Cited by 24
Practical assay and molecular mechanism of aggregation inhibitors of β‐amyloid
Akikusa, S., Watanabe, K., Horikawa, E., NAKAMURA, K. W., Kodaka, M., Okuno, H., & Konakahara, T. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.21028.x · Cited by 22
Identification of Novel Short Peptide Inhibitors of Soluble 37/48 kDa Oligomers of Amyloid β42
Kawasaki, T., Onodera, K., & Kamijo, S. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110198 · Cited by 21
Cited by
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
On the lag phase in amyloid fibril formation
Arosio, P., Knowles, T. P. J., & Linse, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp05563b · Cited by 766
On the binding affinity of macromolecular interactions: daring to ask why proteins interact
Kastritis, P. L., & Bonvin, A. M. J. J. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0835 · Cited by 520
Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)
Theillet, F.-X., Binolfi, A., Frembgen-Kesner, T., Hingorani, K., Sarkar, M., Kyne, C., Li, C., Crowley, P. B., Gierasch, L., Pielak, G. J., et al. (2014) · Chemical Reviews · doi:10.1021/cr400695p · Cited by 503
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
Soragni, A., Janzen, D. M., Johnson, L. M., Lindgren, A. G., Thai-Quynh Nguyen, A., Tiourin, E., Soriaga, A. B., Lu, J., Jiang, L., Faull, K. F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.002 · Cited by 341
Metadata
- Authors
- Härd, T., & Lendel, C.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 421
- Issue
- 4-5
- Pages
- 441-465
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2062071602
- Cited by
- 269
- References
- 280
- FWCI
- 19.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.